National COVID-19 Clinical Evidence Taskforce - Guideline Leadership Group
As part of the National COVID-19 Clinical Evidence Taskforce, the Australian Living Evidence Consortium is developing living Australian guidelines for the clinical care of people with COVID-19. CHF is looking for a second consumer to join the Guidelines Leadership Group and be a co-chair of the Consumer Panel.
DoH - Australian Community Pharmacy Authority
The Australian Community Pharmacy Authority considers applications for approval to supply pharmaceutical benefits under the requirements of the Pharmacy Location Rules determined by the Minister for Health. The Authority makes recommendations as to whether or not the applicant should be approved in relation to particular premises. The National Health Act specifies the membership of the Authority who are appointed by the Minister for Health, with the exception of the Departmental representative who is appointed by the Secretary.
DoH - Pharmaceutical Benefits Advisory Committee (PBAC)
The Department of Health is looking for a consumer for possible appointment to the Pharmaceutical Benefits Advisory Committee (PBAC). Please note that the final decision on the appointment will be at the discretion of the Minister for Health, the Hon Greg Hunt MP.
COORDINARE - Community Advisory Committee
As the South Eastern NSW PHN, COORDINARE provides opportunities for consumers and the community to have a greater say over issues that directly affect the delivery of person-centred, high quality and coordinated/integrated health care throughout the region. COORDINARE’s Community Advisory Committee provides expert advice to the Board on consumer and community engagement strategies to ensure where possible decisions, investments and innovations are inclusive, culturally responsive, locally relevant and aligned to local care experiences and expectations.